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Adrenoleukodystrophy is one of the x-linked genetic disorders presented with 
myelin sheath breakdown in the brain around the nerve cells and progressive adrenal 
insufficiency (1). It is related to the accumulation of very long chain fatty acids 
characterized by cerebral demyelination, adrenomyeloneuropathy and myelopathy 
Abstract 
Objective
Adrenoleukodystrophy disorder is one of the x-linked genetic disorders caused 
by the myelin sheath breakdown in the brain. In this study, we present 4 yr 
experience on this disorder.
Materials & Methods
The patients diagnosed as adrenoleukodystrophy in the Neurology Department 
of Mofid Children’s Hospital in Tehran, Iran from 2010 to 2014 were enrolled 
into the study. The disorder was confirmed by neuroimaging and clinical 
findings along with genetic and neurometabolic assessment at Reference 
Laboratory in Germany. We assessed age, gender, past medical history, 
developmental status, clinical manifestations, and neuroimaging findings of 
populous family with adrenoleukodystrophy. 
Results
All of the patients were one populous family with high rate of consanguineous 
marriages. This disorder was confirmed by genetic assessment, VLCFA and 
brain MRI.
c.253_254insC, p.R85Pfs112* was found in heterozygote state and the 
VLCFA assessment showed the typical pattern for adrenoleukodystrophy/ 
adrenomyeloneuropathy. This diagnosis was in agreement with the family 
history and the clinical history of the patient. Since there have been a number 
of cases in patient’s family in the past, so intensive follow-up on the family 
especially detection the female members of the family of childbearing age was 
recommended. The amount of C-26, C24/C22 and C26/C22 was elevated. All 
patients with the same genotype had wide ranges of clinical presentation.
Conclusion
Early diagnose of this disease might help us for early intervention and prenatal 
diagnosis for the disease in next siblings. 
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Results 
Adrenoleukodystrophy disease was found in five boys of 
one populous family. This disorder approximately was 
started from the age of 6 yr, with seizure and behavior 
disorders specially ADHD in addition to progressive 
motor disorder, ataxia, insomnia etc. All the patients 
had adrenal insufficiency. In supplementary assessment, 
leukodystrophy was found in brain MRI, which showed 
leukodystrophic pattern from posterior to anterior side. 
Adrenoleukodystrophy was confirmed by VLCFA (very 
long chain fatty acid) and genetic assessment. Four 
patients with adrenoleukodystrophy died in the age of 
12-13 yr. One patient suffered and was bedridden due to 
this disorder in the age 24 yr. 
In this group, ALD presented with gait abnormality, 
spasticity, clonus, paresthesia, increased deep tendon 
reflex, positive Romberg, urinary as well as sexual 
system abnormality and occasional headache. 
Some patients suffered from urinary reflux and renal 
failure due to spastic neurogenic bladder. Only one 
patient had Addison’s disease in his age of 41 yr. He 
was stricken to Addison’s disease owing to stress of 
appendicitis surgery and then prednisolone and cortisone 
were prescribed for his insufficiency. Two years before 
his admission, nephrologic presentations, writing 
abnormality and sexuality disorder such as erectile 
dysfunction started. Sensory motor poly neuropathy was 
reported in EMG-NCV of group with homozygote men. 
In another group, women with heterozygote genotype 
of this mutation were completely sign and symptom 
free. The oldest one was 67 yr-old woman with normal 
VLCFA and brain MRI without any symptom.
A 25-yr old woman in this group was offspring of 
consanguineous marriage with gait disorder, spastic 
extremity, urinary abnormality such as urgent 
incontinency and spastic bladder presented since her 22 
yr of age. Her mother was heterozygote for this mutation. 
She had a brother with typical ALD, positive VLCFA, 
confirmed genetic assessment and his brain MRI showed 
leukodystrophic pattern. Her father was positive for 
ALD with leukodystrophic pattern in his brain MRI who 
was bedridden, completely spastic and mild to moderate 
mental status regression with primary manifestation of 
adrenomyeloneuropathy in his 34 yr of age. 
In another family, a 10-yr-old boy died due to ALD. Brain 
(2,3).
Adrenoleukodystrophy is caused due to the ABCD1 
gene defect and resulted to impairment of peroxisomal 
beta-oxidation. The adrenal cortex, CNS and the leydig 
cells of testes are the sites of involvement. The ALD 
phenotypes vary in childhood and adults. Rapidly 
progressive cerebral disease is seen in childhood form 
of ALD. Adrenomyeloneuropathy with or without 
local CNS demyelination is found in adult form of this 
disorder (4). 
In this study, we present 4 years of experience on 
adrenoleukodystrophy from the Pediatric Neurology 
Research Center of Mofid Children’s Hospital, Tehran, 
Iran. We describe clinical symptoms and neuroimaging 
findings for populous family with this disorder. 
Materials & Methods 
This observational study was performed on one 
populous family who lived in Lorestan Province, 
western Iran from 2010 to 2014. Some children of 
this family were diagnosed as adrenoleukodystrophy 
and died owing to this progressive disorder. Whereas 
the rate of consanguineous marriages in this family 
was high and some children were presented with 
adrenoleukodystrophy; all of the family members were 
undergone genetic assessment. Some of the patients with 
positive genetic assessment and various presentations 
of adrenoleukodystrophy such as spasticity, gait 
disorders, urinary  disorders, neurogenic bladder, motor 
slowing, tremor and non-significant manifestations were 
undergone Magnetic Resonance Spectoscopy (MRS). 
The diagnosis was performed based on clinical 
manifestations, neuroimaging findings, VLCFA, and 
genetic assessment in referral laboratories in Germany.
Data analysis
Data were analyzed using descriptive methods and no 
statistical testing was applied. 
Ethical approval
Ethics Committee of Pediatric Neurology Research 
Center, Shahid Beheshti University of Medical Sciences, 
Tehran, Iran approved the study. All parents signed a 
written informed consent for participation in the study. 
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MRI was done because of his headache as a primary 
manifestation, which showed typical leukodystrophic 
pattern, and his disorder was confirmed by VLCFA 
and genetic assessment. He did not have Addison’s 
disease and his brother with negative genotype for ALD 
nominated for bone marrow transplantation. The other 
brother of this boy had similar genotype with confirmed 
ALD in VLCFA but brain MRI was completely normal. 
He underwent special diet with Lorenzo oil and did not 
have any clinical and imaging (Brain MRI) abnormality 
in his annual assessment for at least 3 yr. 
c.253_254insC, p.R85Pfs112* was found in 
heterozygote state by analysis of DNA extraction, 
analysis of previously detected mutation of ABCD1 
gene by PCR and direct sequencing. The above DNA 
change is a frame shift mutation that makes a truncated 
197aa protein in which only the first 85 amino acids 
have original sequence and text 112 amino acids 
are changed. The mutation is novel of no previous 
reported, but certainly is pathogenic. As a sample, the 
VLCFA of one patient showed the typical pattern for 
adrenoleukodystrophy/ adrenomyeloneuropathy. This 
diagnosis was in agreement with the family history and 
the clinical history of the patient. Since there have been 
a number of cases in his family in the past, so intensive 
follow-up on the family especially to have the female 
members of the family of child-bearing age ready to call, 
was recommended. The amount of C-26, C24/C22 and 
C26/C22 was elevated. 
Discussion 
Adrenoleukodystrophy is one of the x-linked recessive 
disorders with variable phenotype and elevated level 
of long chain fatty acids (5). In our study, we present 
adrenoleukodystrophy disease in one populous family. 
However all patients had the same genotype but variable 
presentations were seen. Even the presentations among 
the homozygote man were not similar. With the same 
genotype, ALD presented in one case on his 6 yr of age 
and occurred in another one on his 10 yr of age. The 
brain involvement was different between the similar age 
ranges. Probably, these differences could be justified 
with either diet variation or environmental factors. 
The high levels of hexacosansaure (C-26), tetracosansaure 
(C-24), C24/C22 ratio and C26/C22 ratio are associated 
with intense and more signs and symptoms. 
Semmler et el. in their review article done on patients with 
adrenoleukodystrophy showed that approximately half 
of the heterozygote female had moderate spastic paresis 
resembling the phenotype of adrenomyeloneuropathy. 
They focused on Lorenzo’s oil as a treatment of ALD 
and reported its positive affection in asymptomatic 
patients without cerebral involvement and female 
carriers and VLCFA restriction. It was not effective in 
cerebral inflammatory disease variants (4).
Moser in study that was done on 2000 ALD patients 
reported the diet of glyceryl trierucate and glyceryl 
trioleate oil (Lorenzo’s oil) on ALD treatment. 
Neurological involvement was less severs after treatment 
with Lorenzo’s oil (6). Brett et al. reviewed the genetic 
forms of adrenal deficiency and explained the clinical 
presentation and diagnosis of diseases such as ALD (7). 
Several papers have been published on the ALD 
manifestations and CT scan abnormalities (7, 8). 
Vollkow et al. demonstrated the CT scan, MRI and PET 
results of patients with ALD, where MRI showed a larger 
area of abnormality, which was more sensitive in disease 
detection than CT scan described classical pattern of 
ALD with less clinical findings relationship (9). Moser et 
al. reviewed the effect of Lorenzo’s oil on asymptomatic 
boys with the risk of childhood ALD, which could 
decrease the rate of adrenomyeloneuropathy progression 
(2). Silveri et al. (1) reported the symptoms of lower 
urinary tract among 14 children and adults 8 to 53 yr old 
with different manifestations. They complained voiding 
dysfunction the same as some patients in our study. 
In conclusion, in patients with high number of ALD 
cases in family, intensive follow-up especially on the 
female members of the family of childbearing age should 
be considered and recommended.
Acknowledgments 
We thank Wagnester Laboratory in Germany for 
conducting laboratory tests for neurometabolic disorders. 
In addition, we thank the parents of our patients for their 
cooperation and permission to publish this study. 
Authors’ Contribution
Dr Karimzadeh: Writing of discussion, study designer 
and supervision 
The Clinical Features and Diagnosis of Adrenoleukodystrophy: A Case Series of Iranian Family 
64 Iran J Child Neurol. Winter 2016 Vol 10 No 1
trial of oleic and erucic acids (“Lorenzo’s oil”) as 
treatment for adrenomyeloneuropathy. N Engl J Med 
1993;329(11):745-52.
4. Semmler A, Köhler W, Jung HH, Weller M, Linnebank 
M. Therapy of X-linked adrenoleukodystrophy. Expert 
Rev Neurother 2008;8(9):1367-79.
5. Watkins PA, Gould SJ, Smith MA, Braiterman LT, Wei 
HM, Kok F, Moser AB, Moser HW, Smith KD.Altered 
expression of ALDP in X-linked adrenoleukodystrophy. 
Am J Hum Genet 1995;57(2):292-301.
6. Moser HW. Komrower Lecture. Adrenoleukodystrophy: 
natural history, treatment and outcome. J Inherit Metab 
Dis 1995;18(4):435-47.
7. Brett EM, Auchus RJ. Genetic Forms of Adrenal 
Insufficiency. Endocr Pract 2015:1-17.
8. Eiben RM, DiChiro G. Computer assisted tomography 
in adrenoleukodystrophy. J Comput Assist Tom Ogr Ml 
1:308-317.
9. Volkow ND, Patchell L, Kulkarni MV, Reed K, Simmons 
M.Adrenoleukodystrophy: imaging with CT, MRI, and 
PET. J Nucl Med 1987;28(4):524-7.
Dr Jafari: Author of Introduction
Dr Habibeh Nejad Biglari: Study designer
Dr Jabbehdari: First draft of the article in English
Dr Mehdi Alizadeh: Provider of Radiologic data
Dr Ghazal: Provider of data
Dr Sanii and Dr Hamid Nejad Biglari: Literature editor
Conflicting of interest: None declared
References
1. Silveri M, De Gennaro M, Gatti C, Bizzarri C, 
Mosiello G, Cappa M. Voiding dysfunction in x-linked 
adrenoleukodystrophy: symptom score and urodynamic 
findings. J Urol 2004;171(6 Pt 2):2651-3.
2. Moser HW, Moser AB, Hollandsworth K, Brereton NH, 
Raymond GV. “Lorenzo’s oil” therapy for X-linked 
adrenoleukodystrophy: rationale and current assessment 
of efficacy. J Mol Neurosci 2007;33(1):105-13.
3. Aubourg P, Adamsbaum C, Lavallard-Rousseau MC, 
Rocchiccioli F, Cartier N, Jambaqué I, Jakobezak C, 
Lemaitre A, Boureau F, Wolf C, et al. A two-year 
The Clinical Features and Diagnosis of Adrenoleukodystrophy: A Case Series of Iranian Family 
